Registry for women with breast implant-associated lymphoma
Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry
This study is collecting information from women with a rare type of lymphoma linked to breast implants to help doctors understand and manage the condition better.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 150 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | The Lymphoma Academic Research Organisation Academic / other |
| Locations | 31 sites (Bruges and 30 other locations) |
| Trial ID | NCT04220970 on ClinicalTrials.gov |
What this trial studies
This registry aims to collect data on women diagnosed with anaplastic large cell lymphoma associated with breast implants (BIA-ALCL). It is established in France and Belgium to better understand this rare condition and facilitate multidisciplinary discussions regarding patient care. The registry will gather clinical information to improve awareness and management of BIA-ALCL among healthcare professionals. By documenting cases, the registry seeks to enhance knowledge about the disease's incidence and outcomes.
Who should consider this trial
Good fit: Ideal candidates for this registry are adult women diagnosed with anaplastic large cell lymphoma associated with breast implants.
Not a fit: Patients without breast implants or those not diagnosed with BIA-ALCL will not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could lead to improved diagnosis, treatment, and management strategies for patients with BIA-ALCL.
How similar studies have performed: While this registry approach is novel for BIA-ALCL, similar registries for rare diseases have shown success in improving patient outcomes and understanding of the conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients with an anaplastic large cell lymphoma associated with breast implants Exclusion Criteria: \-
Where this trial is running
Bruges and 30 other locations
- A. Z. Sint-Jan Brugge-Oostende AV — Bruges, Belgium (Recruiting)
- Clinique Universitaire Saint LUC — Brussels, Belgium (Recruiting)
- Cliniques Universitaires de Bruxelles - Hôpital Erasme — Brussels, Belgium (Not_yet_recruiting)
- Institut Jules Bordet — Brussels, Belgium (Recruiting)
- Universitair Ziekenhuis Brussel — Brussels, Belgium (Not_yet_recruiting)
- Universitair Ziekenhuis Antwerpen — Edegem, Belgium (Not_yet_recruiting)
- Universitair Ziekenhuis Gent — Ghent, Belgium (Recruiting)
- U.Z. Leuven - Campus Gasthuisberg — Leuven, Belgium (Recruiting)
- CHU de Liège -Domaine Sart Tilman — Liège, Belgium (Recruiting)
- CHU UCL Namur - Site Godinne — Yvoir, Belgium (Recruiting)
- CH d Avignon - Hopital Henri Duffaut — Avignon, France (Recruiting)
- Institut Bergonié — Bordeaux, France (Recruiting)
- CHRU de Brest - Hôpital Morvan — Brest, France (Recruiting)
- Hopital Louis Pasteur — Colmar, France (Recruiting)
- APHP - Hopital Henri Mondor — Créteil, France (Recruiting)
- CHU de Dijon - Hôpital le Bocage — Dijon, France (Recruiting)
- Centre Médical la Roseraie — Lille, France (Recruiting)
- Centre Léon Bérard — Lyon, France (Recruiting)
- Institut Paoli Calmettes — Marseille, France (Recruiting)
- CH Saint-Eloi — Montpellier, France (Recruiting)
- CHU de Nantes - Hôtel Dieu — Nantes, France (Recruiting)
- Hôpital Cochin — Paris, France (Recruiting)
- CH de Pau — Pau, France (Recruiting)
- CH de Perpigan — Perpignan, France (Recruiting)
- Centre Hospitalier Lyon Sud — Pierre-Bénite, France (Recruiting)
- Chu de Reims - Hopital Robert Debre — Reims, France (Recruiting)
- Centre Henri Becquerel — Rouen, France (Recruiting)
- Centre Rene Hugenin — Saint-Cloud, France (Recruiting)
- CH de Saint Malo — St-Malo, France (Recruiting)
- CHRU de Strasbourg — Strasbourg, France (Recruiting)
- Institut Universitaire du Cancer - Oncopole Toulouse (IUCT-O) — Toulouse, France (Recruiting)
Study contacts
- Study coordinator: Manon Croix
- Email: manon.croix.ext@lysarc.org
- Phone: +33 (04) 72 66 93 33
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.